Massachusetts Financial Services
AMRX icon

Massachusetts Financial Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Massachusetts Financial Services’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-127,087
Closed -$1.58M – 1008
2026
Q1 		$1.58M Sell
127,087
-48,290
-28% -$648K ﹤0.01% 812
2025
Q4 		$2.21M Sell
175,377
-5,800
-3% -$66.4K ﹤0.01% 783
2025
Q3 		$1.81M Buy
181,177
+11,918
+7% +$107K ﹤0.01% 770
2025
Q2 		$1.37M Buy
169,259
+2,091
+1% +$15.8K ﹤0.01% 792
2025
Q1 		$1.4M Sell
167,168
-3,810
-2% -$31.8K ﹤0.01% 784
2024
Q4 		$1.35M Sell
170,978
-19,684
-10% -$165K ﹤0.01% 789
2024
Q3 		$1.59M Sell
190,662
-4,617
-2% -$36.1K ﹤0.01% 754
2024
Q2 		$1.24M Sell
195,279
-26,528
-12% -$168K ﹤0.01% 782
2024
Q1 		$1.34M Buy
+221,807
New +$1.25M ﹤0.01% 761
2022
Q2 		– Sell
-79,942
Closed -$333K – 848
2022
Q1 		$333K Buy
79,942
+819
+1% +$3.63K ﹤0.01% 840
2021
Q4 		$379K Sell
79,123
-1,602
-2% -$7.99K ﹤0.01% 867
2021
Q3 		$431K Sell
80,725
-1,059
-1% -$5.33K ﹤0.01% 882
2021
Q2 		$419K Buy
81,784
+700
+0.9% +$3.98K ﹤0.01% 884
2021
Q1 		$546K Sell
81,084
-9,611
-11% -$53.3K ﹤0.01% 878
2020
Q4 		$414K Buy
+90,695
New +$402K ﹤0.01% 850
2018
Q3 		– Sell
-89,933
Closed -$1.48M – 854
2018
Q2 		$1.48M Buy
+89,933
New +$1.58M ﹤0.01% 738

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Massachusetts Financial Services's AMRX Position: Q2 2026 in Review

Massachusetts Financial Services sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 127,087 shares — an estimated $1.58M sold.

Massachusetts Financial Services first reported a position in AMRX in Q2 2018 and held it in 16 quarters. The position peaked at $2.21M in Q4 2025. 231 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Massachusetts Financial Services reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Massachusetts Financial Services sold 127,087 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.58M.
  • Massachusetts Financial Services first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 16 quarters.
  • Massachusetts Financial Services's Amneal Pharmaceuticals position peaked at $2.21M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.